MOSS — Moss Genomics Balance Sheet
0.000.00%
- CA$2.76m
- CA$2.30m
Annual balance sheet for Moss Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.001 | 0.001 | 0.688 | 0.018 | 0.012 |
| Net Total Receivables | 0.008 | 0.108 | 0.002 | 0.016 | 0.02 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.009 | 0.109 | 0.689 | 0.06 | 0.032 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 0.112 | 0.067 | 0.041 |
| Total Assets | 0.009 | 0.109 | 0.802 | 0.127 | 0.073 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.012 | 0.12 | 0.14 | 0.051 | 0.099 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.012 | 0.12 | 0.14 | 0.051 | 0.099 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.003 | -0.012 | 0.661 | 0.076 | -0.027 |
| Total Liabilities & Shareholders' Equity | 0.009 | 0.109 | 0.802 | 0.127 | 0.073 |
| Total Common Shares Outstanding |